Angle PLC Announces Notice of Interim Results and Webcast
ANGLE plc (AIM:AGL OTCQX:ANPCY), a leading liquid biopsy company specializing in circulating tumour cell (CTC) solutions, has announced the release of its interim results for the six months ended 30 June 2024. The results will be published on Thursday 26 September 2024.
An analyst meeting is scheduled for 11:00 am BST on the same day at Berenberg's offices in London. A live webcast of the meeting will be accessible through ANGLE's Investor Centre page, with Q&A participation reserved for analysts. The webcast recording will be made available on ANGLE's website following the event.
ANGLE plc (AIM:AGL OTCQX:ANPCY), una delle principali aziende nel settore delle biopsie liquide specializzata in soluzioni per le cellule tumorali circolanti (CTC), ha annunciato il rilascio dei suoi risultati intermedi per i sei mesi chiusi il 30 giugno 2024. I risultati verranno pubblicati il giovedì 26 settembre 2024.
È programmato un incontro con gli analisti alle 11:00 ora BST nello stesso giorno negli uffici di Berenberg a Londra. Un webcast dal vivo dell'incontro sarà accessibile tramite la pagina del Centro Investor di ANGLE, con la partecipazione alle domande riservata agli analisti. La registrazione del webcast sarà disponibile sul sito web di ANGLE dopo l'evento.
ANGLE plc (AIM:AGL OTCQX:ANPCY), una empresa líder en biopsias líquidas especializada en soluciones para células tumorales circulantes (CTC), ha anunciado la publicación de sus resultados interinos para los seis meses finalizados el 30 de junio de 2024. Los resultados se publicarán el jueves 26 de septiembre de 2024.
Se ha programado una reunión con analistas a las 11:00 a.m. BST el mismo día en las oficinas de Berenberg en Londres. Un transmisión en vivo de la reunión será accesible a través de la página del Centro de Inversores de ANGLE, con la participación en la sesión de preguntas reservada para los analistas. La grabación de la transmisión se hará disponible en el sitio web de ANGLE tras el evento.
ANGLE plc (AIM:AGL OTCQX:ANPCY)는 순환 종양 세포(CTC) 솔루션을 전문으로 하는 선도적인 액체 생검 회사로, 2024년 6월 30일 종료된 6개월에 대한 중간 결과 발표를 발표했습니다. 결과는 2024년 9월 26일 목요일에 발표될 예정입니다.
동일한 날 오전 11:00 BST에 런던 베렌베르크 사무소에서 애널리스트 회의가 예정되어 있습니다. 회의의 실시간 웹캐스트는 ANGLE의 투자자 센터 페이지를 통해 접근 가능하며, Q&A 세션은 애널리스트를 위해 예약되어 있습니다. 웹캐스트 녹화는 이벤트 이후 ANGLE 웹사이트에서 제공될 것입니다.
ANGLE plc (AIM:AGL OTCQX:ANPCY), une entreprise leader dans le domaine des biopsies liquides spécialisée dans les solutions pour les cellules tumorales circulantes (CTC), a annoncé la publication de ses résultats intermédiaires pour les six mois se terminant le 30 juin 2024. Les résultats seront publiés le jeudi 26 septembre 2024.
Une réunion avec les analystes est prévue à 11h00 BST le même jour dans les bureaux de Berenberg à Londres. Un webinaire en direct de la réunion sera accessible via la page du Centre des Investisseurs d'ANGLE, avec la participation des questions réservée aux analystes. L'enregistrement du webinaire sera disponible sur le site web d'ANGLE après l'événement.
ANGLE plc (AIM:AGL OTCQX:ANPCY), ein führendes Unternehmen im Bereich der Flüssigbiopsien, das sich auf Lösungen für zirkulierende Tumorzellen (CTC) spezialisiert hat, hat die Veröffentlichung seiner vorläufigen Ergebnisse für die sechs Monate bis zum 30. Juni 2024 angekündigt. Die Ergebnisse werden am Donnerstag, den 26. September 2024 veröffentlicht.
Ein Analystentreffen ist für 11:00 Uhr BST am selben Tag in den Büros von Berenberg in London angesetzt. Ein Live-Webcast des Treffens wird über die Investorenseite von ANGLE zugänglich sein, wobei die Teilnahme an der Q&A-Sitzung den Analysten vorbehalten ist. Die Aufzeichnung des Webcasts wird nach der Veranstaltung auf der Website von ANGLE verfügbar gemacht.
- None.
- None.
Notice of Interim Results and Webcast
GUILDFORD, SURREY / ACCESSWIRE / September 17, 2024 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, will be releasing its interim results for the six months ended 30 June 2024 on Thursday 26 September 2024.
A meeting for analysts will be held at 11:00 am BST on Thursday 26 September 2024 at the offices of Berenberg, 60 Threadneedle Street, London EC2R 8HP.
A live webcast of the analyst meeting can be accessed via ANGLE's Investor Centre page, https://angleplc.com/investor-relations/corporate-presentations/, with Q&A participation reserved for analysts only. Please register in advance and log on to the webcast approximately 5 minutes before 11:00 am on the day of the results. A recording of the webcast will be made available on ANGLE's website following the results meeting.
For further information:
ANGLE plc | +44 (0) 1483 343434 |
Andrew Newland, Chief Executive |
|
Berenberg (NOMAD and Broker) | +44 (0) 20 3207 7800 |
FTI Consulting | +44 (0) 203 727 1000 |
For Frequently Used Terms, please see the Company's website on https://angleplc.com/investor-relations/glossary/
Notes for editors
About ANGLE plc
ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected CTC harvesting technology, known as the Parsortix® PC1 system, enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.
ANGLE's commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. The clinical services business is offered through ANGLE's GCLP-compliant laboratories in the UK. Services include custom made assay development and clinical trial testing for pharma.
Over 90 peer-reviewed publications have demonstrated the performance of the Parsortix system. For more information, visit www.angleplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
SOURCE: ANGLE plc
View the original press release on accesswire.com
FAQ
When will ANGLE plc (ANPCY) release its interim results for H1 2024?
Where can I access the live webcast of ANGLE plc's (ANPCY) analyst meeting on 26 September 2024?
What time is ANGLE plc's (ANPCY) analyst meeting scheduled for on 26 September 2024?
Where will ANGLE plc's (ANPCY) analyst meeting be held on 26 September 2024?
